[go: up one dir, main page]

PL360297A1 - Kompozycje farmaceutyczne zawierające akryloilowepochodne dystamycyny i inhibitory topoizomerazy Ii II - Google Patents

Kompozycje farmaceutyczne zawierające akryloilowepochodne dystamycyny i inhibitory topoizomerazy Ii II

Info

Publication number
PL360297A1
PL360297A1 PL36029701A PL36029701A PL360297A1 PL 360297 A1 PL360297 A1 PL 360297A1 PL 36029701 A PL36029701 A PL 36029701A PL 36029701 A PL36029701 A PL 36029701A PL 360297 A1 PL360297 A1 PL 360297A1
Authority
PL
Poland
Prior art keywords
topoisomerase
inhibitors
distamycin derivatives
acryloyl distamycin
combined therapy
Prior art date
Application number
PL36029701A
Other languages
English (en)
Other versions
PL200503B1 (pl
Inventor
Maria Cristina Rosa Geroni
Paolo Cozzi
Italo Beria
Original Assignee
Pharmacia Italia S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.
Publication of PL360297A1 publication Critical patent/PL360297A1/pl
Publication of PL200503B1 publication Critical patent/PL200503B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL360297A 2000-06-23 2001-06-20 Kompozycja farmaceutyczna zawierająca pochodną dystamycyny, produkt zawierający pochodną dystamycyny oraz zastosowanie pochodnej dystamycyny PL200503B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015444.3A GB0015444D0 (en) 2000-06-23 2000-06-23 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
PCT/EP2001/007059 WO2001097789A2 (en) 2000-06-23 2001-06-20 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors

Publications (2)

Publication Number Publication Date
PL360297A1 true PL360297A1 (pl) 2004-09-06
PL200503B1 PL200503B1 (pl) 2009-01-30

Family

ID=9894285

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360297A PL200503B1 (pl) 2000-06-23 2001-06-20 Kompozycja farmaceutyczna zawierająca pochodną dystamycyny, produkt zawierający pochodną dystamycyny oraz zastosowanie pochodnej dystamycyny

Country Status (27)

Country Link
US (1) US20030162722A1 (pl)
EP (1) EP1292290B1 (pl)
JP (1) JP2003535890A (pl)
KR (1) KR100853955B1 (pl)
CN (1) CN1241573C (pl)
AT (1) ATE323483T1 (pl)
AU (2) AU7846301A (pl)
BR (1) BR0111813A (pl)
CA (1) CA2411172C (pl)
CZ (1) CZ20024155A3 (pl)
DE (1) DE60118914T2 (pl)
DK (1) DK1292290T3 (pl)
EA (1) EA006684B1 (pl)
EE (1) EE05319B1 (pl)
ES (1) ES2261448T3 (pl)
GB (1) GB0015444D0 (pl)
HK (1) HK1054334B (pl)
HU (1) HUP0301257A2 (pl)
IL (1) IL153177A0 (pl)
MX (1) MXPA02012163A (pl)
NO (1) NO329783B1 (pl)
NZ (1) NZ523000A (pl)
PL (1) PL200503B1 (pl)
PT (1) PT1292290E (pl)
SK (1) SK287549B6 (pl)
WO (1) WO2001097789A2 (pl)
ZA (1) ZA200209834B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
EP1461083B1 (en) * 2002-01-02 2006-03-29 Pharmacia Italia S.p.A. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
CN100438913C (zh) * 2004-11-22 2008-12-03 山东蓝金生物工程有限公司 一种抗癌药物组合物
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
AU2011274229A1 (en) 2010-07-02 2013-01-10 Angiochem Inc. Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
CN109718228A (zh) * 2017-10-30 2019-05-07 沈阳药科大学 米托蒽醌的抗肿瘤淋巴转移作用及其药物制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors

Also Published As

Publication number Publication date
DE60118914D1 (de) 2006-05-24
JP2003535890A (ja) 2003-12-02
NO329783B1 (no) 2010-12-13
KR100853955B1 (ko) 2008-08-25
BR0111813A (pt) 2003-05-20
AU7846301A (en) 2002-01-02
CZ20024155A3 (cs) 2003-04-16
ES2261448T3 (es) 2006-11-16
GB0015444D0 (en) 2000-08-16
DE60118914T2 (de) 2006-12-21
EE05319B1 (et) 2010-08-16
AU2001278463B2 (en) 2006-02-23
NO20026078D0 (no) 2002-12-18
HK1054334A1 (en) 2003-11-28
EP1292290A2 (en) 2003-03-19
HUP0301257A2 (hu) 2003-08-28
CA2411172A1 (en) 2001-12-27
DK1292290T3 (da) 2006-07-10
SK287549B6 (sk) 2011-01-04
ZA200209834B (en) 2003-12-04
US20030162722A1 (en) 2003-08-28
HK1054334B (zh) 2006-09-22
EA200300060A1 (ru) 2003-04-24
SK18332002A3 (sk) 2003-07-01
NO20026078L (no) 2002-12-18
CN1437474A (zh) 2003-08-20
MXPA02012163A (es) 2003-04-25
WO2001097789A2 (en) 2001-12-27
EE200200681A (et) 2004-06-15
CA2411172C (en) 2009-11-17
WO2001097789A3 (en) 2002-05-16
NZ523000A (en) 2005-12-23
EA006684B1 (ru) 2006-02-24
EP1292290B1 (en) 2006-04-19
KR20030019448A (ko) 2003-03-06
CN1241573C (zh) 2006-02-15
PL200503B1 (pl) 2009-01-30
ATE323483T1 (de) 2006-05-15
PT1292290E (pt) 2006-08-31
IL153177A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
HK1054334A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
CY1106713T1 (el) Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες
MXPA03004023A (es) Compuestos quimicos.
MXPA02012165A (es) Terapia combinada contra tumores que comprende derivados de acriloil-distamicina sustituida, taxanos y/o antimetabolitos.
IL162820A0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110620